The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| 4D MOLECULAR THERAPEUTICS IN | COM | 35104E100 | 20,017 | 831,267 | SH | SOLE | 831,267 | 0 | 0 | ||
| ACCELERON PHARMA INC | COM | 00434H108 | 14,100 | 112,363 | SH | SOLE | 112,363 | 0 | 0 | ||
| AMBRX BIOPHARMA INC | SPONSORED ADS | 02290A102 | 8,820 | 450,000 | SH | SOLE | 450,000 | 0 | 0 | ||
| APELLIS PHARMACEUTICALS INC | COM | 03753U106 | 79,396 | 1,256,265 | SH | SOLE | 1,256,265 | 0 | 0 | ||
| ARCUS BIOSCIENCES INC | COM | 03969F109 | 20,874 | 760,164 | SH | SOLE | 760,164 | 0 | 0 | ||
| ARVINAS INC | COM | 04335A105 | 13,745 | 178,500 | SH | SOLE | 178,500 | 0 | 0 | ||
| AVIDITY BIOSCIENCES INC | COM | 05370A108 | 11,036 | 446,641 | SH | SOLE | 446,641 | 0 | 0 | ||
| BRIDGEBIO PHARMA INC | COM | 10806X102 | 23,221 | 380,928 | SH | SOLE | 380,928 | 0 | 0 | ||
| CARDIFF ONCOLOGY INC | COM | 14147L108 | 6,535 | 982,753 | SH | SOLE | 982,753 | 0 | 0 | ||
| CELLDEX THERAPEUTICS INC NEW | COM NEW | 15117B202 | 18,773 | 561,398 | SH | SOLE | 561,398 | 0 | 0 | ||
| CENTURY THERAPEUTICS INC | COM | 15673T100 | 11,839 | 403,523 | SH | SOLE | 403,523 | 0 | 0 | ||
| CONNECT BIOPHARMA HLDGS LTD | ADS | 207523101 | 7,294 | 373,492 | SH | SOLE | 373,492 | 0 | 0 | ||
| CURIS INC | COM NEW | 231269200 | 28,912 | 3,582,629 | SH | SOLE | 3,582,629 | 0 | 0 | ||
| DESIGN THERAPEUTICS INC | COM | 25056L103 | 4,973 | 250,000 | SH | SOLE | 250,000 | 0 | 0 | ||
| DYNE THERAPEUTICS INC | COM | 26818M108 | 12,280 | 583,649 | SH | SOLE | 583,649 | 0 | 0 | ||
| EDGEWISE THERAPEUTICS INC | COM | 28036F105 | 2,666 | 125,000 | SH | SOLE | 125,000 | 0 | 0 | ||
| GOSSAMER BIO INC | COM | 38341P102 | 11,475 | 1,413,138 | SH | SOLE | 1,413,138 | 0 | 0 | ||
| HELIX ACQUISITION CORP | COM CL A | G4444C102 | 4,132 | 400,000 | SH | SOLE | 400,000 | 0 | 0 | ||
| I MAB | SPONSORED ADS | 44975P103 | 79,178 | 943,156 | SH | SOLE | 943,156 | 0 | 0 | ||
| IKENA ONCOLOGY INC | COM | 45175G108 | 5,616 | 400,000 | SH | SOLE | 400,000 | 0 | 0 | ||
| IVERIC BIO INC | COM | 46583P102 | 4,291 | 680,036 | SH | SOLE | 680,036 | 0 | 0 | ||
| JIYA ACQUISITION CORP | COM CL A | 47760M102 | 2,982 | 300,000 | SH | SOLE | 300,000 | 0 | 0 | ||
| KRONOS BIO INC | COM | 50107A104 | 3,501 | 146,173 | SH | SOLE | 146,173 | 0 | 0 | ||
| KYMERA THERAPEUTICS INC | COM | 501575104 | 4,850 | 100,000 | SH | SOLE | 100,000 | 0 | 0 | ||
| MERUS N V | COM | N5749R100 | 4,360 | 206,927 | SH | SOLE | 206,927 | 0 | 0 | ||
| MONTE ROSA THERAPEUTICS INC | COM | 61225M102 | 5,404 | 238,045 | SH | SOLE | 238,045 | 0 | 0 | ||
| NGM BIOPHARMACEUTICALS INC | COM | 62921N105 | 3,944 | 200,000 | SH | SOLE | 200,000 | 0 | 0 | ||
| PMV PHARMACEUTICALS INC | COM | 69353Y103 | 8,540 | 250,000 | SH | SOLE | 250,000 | 0 | 0 | ||
| PROMETHEUS BIOSCIENCES INC | COM | 74349U108 | 4,912 | 200,000 | SH | SOLE | 200,000 | 0 | 0 | ||
| REVOLUTION MEDICINES INC | COM | 76155X100 | 4,004 | 126,136 | SH | SOLE | 126,136 | 0 | 0 | ||
| STOKE THERAPEUTICS INC | COM | 86150R107 | 9,991 | 296,822 | SH | SOLE | 296,822 | 0 | 0 | ||
| TAYSHA GENE THERAPIES INC | COM SHS | 877619106 | 6,793 | 320,440 | SH | SOLE | 320,440 | 0 | 0 | ||
| VERA THERAPEUTICS INC | CL A | 92337R101 | 15,008 | 1,132,671 | SH | SOLE | 1,132,671 | 0 | 0 | ||
| ZAI LAB LTD | ADR | 98887Q104 | 19,351 | 109,335 | SH | SOLE | 109,335 | 0 | 0 | ||